Trial intelligence / Profile preview

Acitretin added to Etanercept in Moderate to Severe Psoriasis

NCT00156247Phase 2Completed

Sponsor
University of Medicine and Dentistry of New Jersey
Start
Sep 2005
Primary completion
Mar 2009
Modality
Orthosteric Ligands
01

Overview

A Phase 2 trial of acitretin in psoriasis, sponsored by University of Medicine and Dentistry of New Jersey. Started Sep 2005; status: completed.

02

Drugs

acitretin
03

Conditions

psoriasis

Beyond the preview

Go deeper on NCT00156247.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00156247.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call